欧洲与美国肾脏替代治疗性别差异比较:ERA与USRDS登记数据
该研究基于2022年ERA登记与美国USRDS数据,比较两地肾脏替代治疗(KRT)的发病率、患病率、肾移植率及KRT死亡率,并作性别对比。美国KRT发病率是欧洲的2.7倍(女性3.2倍,男性2.4倍),患病率、移植率和死亡率亦更高,且两地差异在女性中更大。
要点
- 美国KRT发病率388.7 pmp,欧洲146.2 pmp,女性差异(3.2倍)大于男性(2.4倍)。
- 美国KRT患病率2444.2 pmp,欧洲1218.6 pmp,女性占比欧洲38%低于美国41%。
- 美国KRT死亡率145.0/1000 py,欧洲100.5/1000 py,女性差异(1.6倍)大于男性(1.4倍)。
核心结论
- 美国KRT发病率、患病率、肾移植率和死亡率均高于欧洲,且性别差异在女性中更大。
研究设计与样本
- 基于2022年欧洲ERA登记和美国USRDS的 population-based 数据,比较KRT相关指标及性别差异。
主要发现
- 美国KRT发病率388.7 pmp,欧洲146.2 pmp,女性为3.2倍差异,男性2.4倍。
- 欧洲女性KRT发病占比35%,美国41%;2013-2022年欧洲女性发病率稳定(+0.1%/年),男性增加(+1.1%/年)。
- 美国KRT患病率2444.2 pmp,欧洲1218.6 pmp,女性2.2倍,男性1.9倍。
- 美国肾移植率79.1 pmp,欧洲45.4 pmp,女性1.9倍,男性1.7倍;女性受者占比欧洲37%,美国39%。
- 美国KRT死亡率145.0/1000 py,欧洲100.5/1000 py;欧洲女性死亡率93.7/1000 py低于男性104.6/1000 py,美国女性148.9/1000 py高于男性142.2/1000 py。
临床怎么用
- 关注女性KRT发病和移植率的地区差异,优化性别特异性诊疗策略。
- 美国KRT死亡率较高,尤其女性,需加强透析患者管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This article compares the incidence and prevalence of kidney replacement therapy (KRT), kidney transplantation rates and mortality on KRT between Europe and the USA, including sex comparisons. METHODS: Data were derived for 2022 from the population-based European Renal Association (ERA) Registry and the United States Renal Data System (USRDS). RESULTS: In 2022, the KRT incidence in the USA [388.7 per million population (pmp)] was 2.7-fold higher than in Europe (146.2 pmp), with a greater difference for women (3.2-fold) than for men (2.4-fold). The proportion of women initiating KRT was lower in Europe (35%) than in the USA (41%). Between 2013 and 2022, the KRT incidence in Europe was stable in women (+0.1% annually) but increased in men (+1.1%). In the USA, the KRT incidence increased similarly in women (+0.2%) and men (+0.3%). On 31 December 2022, the KRT prevalence was 2-fold (women 2.2-fold, men 1.9-fold) higher in the USA (2444.2 pmp) than in Europe (1218.6 pmp). The proportion of women was lower in Europe (38%) than in the USA (41%). The kidney transplantation rate was 1.7-fold higher in the USA (79.1 pmp) than in Europe (45.4 pmp), 1.9-fold for women and 1.7-fold for men, with women accounting for 37% of the recipients versus 39% in the USA. The KRT mortality rate was 1.5 times higher in the USA [145.0 per 1000 patient-years (py)] compared with Europe (100.5 per 1000 py): 1.6-fold for women and 1.4-fold for men. In Europe, mortality was lower for women receiving KRT (93.7 per 1000 py) than for men (104.6 per 1000 py), whereas in the USA the reverse was true (women 148.9 per 1000 py, men 142.2 per 1000 py). CONCLUSION: The US had a notably higher KRT incidence, prevalence, kidney transplantation rate and mortality compared with Europe. Differences between Europe and the USA were larger for women than for men.
引用
- Stel VS, Chesnaye NC, Boenink R, et al. Kidney replacement therapy for men and women according to the ERA Registry and the USRDS. Nephrol Dial Transplant. 2026. PMID: 41172240. doi:10.1093/ndt/gfaf233
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。